Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP326330.RAYo90Mm8VNNKc_MjH2LREsZm3gouxMbc9eH_HUg2cqXk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP326330.RAYo90Mm8VNNKc_MjH2LREsZm3gouxMbc9eH_HUg2cqXk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP326330.RAYo90Mm8VNNKc_MjH2LREsZm3gouxMbc9eH_HUg2cqXk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP326330.RAYo90Mm8VNNKc_MjH2LREsZm3gouxMbc9eH_HUg2cqXk130_provenance.
- NP326330.RAYo90Mm8VNNKc_MjH2LREsZm3gouxMbc9eH_HUg2cqXk130_assertion description "[We examined the association between this SLCO1B3 polymorphism and time from ADT to androgen independence, ADT to prostate-specific antigen (PSA) nadir and PSA nadir to androgen independence in 68 Caucasian patients with advanced prostate cancer who were treated with ADT with metastatic disease (D2) or biochemical failure with no metastatic disease (D0).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP326330.RAYo90Mm8VNNKc_MjH2LREsZm3gouxMbc9eH_HUg2cqXk130_provenance.
- NP326330.RAYo90Mm8VNNKc_MjH2LREsZm3gouxMbc9eH_HUg2cqXk130_assertion evidence source_evidence_literature NP326330.RAYo90Mm8VNNKc_MjH2LREsZm3gouxMbc9eH_HUg2cqXk130_provenance.
- NP326330.RAYo90Mm8VNNKc_MjH2LREsZm3gouxMbc9eH_HUg2cqXk130_assertion SIO_000772 18537956 NP326330.RAYo90Mm8VNNKc_MjH2LREsZm3gouxMbc9eH_HUg2cqXk130_provenance.
- NP326330.RAYo90Mm8VNNKc_MjH2LREsZm3gouxMbc9eH_HUg2cqXk130_assertion wasDerivedFrom befree-20140225 NP326330.RAYo90Mm8VNNKc_MjH2LREsZm3gouxMbc9eH_HUg2cqXk130_provenance.
- NP326330.RAYo90Mm8VNNKc_MjH2LREsZm3gouxMbc9eH_HUg2cqXk130_assertion wasGeneratedBy ECO_0000203 NP326330.RAYo90Mm8VNNKc_MjH2LREsZm3gouxMbc9eH_HUg2cqXk130_provenance.
- befree-20140225 importedOn "2014-02-25" NP326330.RAYo90Mm8VNNKc_MjH2LREsZm3gouxMbc9eH_HUg2cqXk130_provenance.